Hassman Research Institute (HRI) In response to continuing COVID-19 developments, HRI has proactively implemented the safety precautions recommended by the CDC, WHO, FDA, and other government agencies. These include (but are not limited to): the administration of daily patient screening questionnaires regarding COVID19 symptoms to reduce risk, the utilization of staff and patient health checks and personal protections to heighten safety, and the increase and intensification of cleaning/disinfecting measures throughout the facilities to further safeguard the community. In addition, all those that screen-in for any inpatient studies are tested for COVID-19 prior to entering the inpatient unit.